R-(-)-Deprenyl hydrochloride (Cat.No:I001769) is a pharmaceutical compound primarily used to treat Parkinson’s disease. It is a selective and irreversible inhibitor of monoamine oxidase type B (MAO-B), an enzyme that breaks down neurotransmitters in the brain. By inhibiting MAO-B, R-(-)-Deprenyl hydrochloride helps increase dopamine levels, improving motor symptoms and quality of life in Parkinson’s patients.
| Catalog Number | I001769 |
| CAS Number | 14611-52-0 |
| Synonyms | L-Deprenyl;Selegiline |
| Molecular Formula | C13H17N • HCl |
| Purity | 95% |
| Target | Monoamine oxidase B |
| Solubility | 10 mM in DMSO |
| Storage | -20°C |
| InChIKey | IYETZZCWLLUHIJ-UTONKHPSSA-N |
| Reference | </br>1:In vitro interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection. Galgóczy L, Tóth L, Virágh M, Papp T, Vágvölgyi CS.Acta Biol Hung. 2012 Dec;63(4):490-500. doi: 10.1556/ABiol.63.2012.4.8. PMID: 23134606 </br>2:The Effect of Dosing Regimen and Food on the Bioavailability of the Extensively Metabolized, Highly Variable Drug Eldepryl(®) (Selegiline Hydrochloride). Barrett JS, Rohatagi S, DeWitt KE, Morales RJ, DiSanto AR.Am J Ther. 1996 Apr;3(4):298-313. PMID: 11862265 |
